GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Nidan Laboratories and Healthcare Ltd (NSE:NIDAN) » Definitions » ROA %

Nidan Laboratories and Healthcare (NSE:NIDAN) ROA % : 2.85% (As of Mar. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Nidan Laboratories and Healthcare ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Nidan Laboratories and Healthcare's annualized Net Income for the quarter that ended in Mar. 2023 was ₹24.4 Mil. Nidan Laboratories and Healthcare's average Total Assets over the quarter that ended in Mar. 2023 was ₹858.5 Mil. Therefore, Nidan Laboratories and Healthcare's annualized ROA % for the quarter that ended in Mar. 2023 was 2.85%.

The historical rank and industry rank for Nidan Laboratories and Healthcare's ROA % or its related term are showing as below:

NSE:NIDAN' s ROA % Range Over the Past 10 Years
Min: -3.87   Med: 2.68   Max: 4.65
Current: 4.24

During the past 6 years, Nidan Laboratories and Healthcare's highest ROA % was 4.65%. The lowest was -3.87%. And the median was 2.68%.

NSE:NIDAN's ROA % is ranked better than
72.89% of 225 companies
in the Medical Diagnostics & Research industry
Industry Median: -4.83 vs NSE:NIDAN: 4.24

Nidan Laboratories and Healthcare ROA % Historical Data

The historical data trend for Nidan Laboratories and Healthcare's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nidan Laboratories and Healthcare ROA % Chart

Nidan Laboratories and Healthcare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROA %
Get a 7-Day Free Trial 1.62 4.65 3.74 4.09 -3.87

Nidan Laboratories and Healthcare Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Mar24
ROA % Get a 7-Day Free Trial 6.71 1.94 5.28 2.85 -

Competitive Comparison of Nidan Laboratories and Healthcare's ROA %

For the Diagnostics & Research subindustry, Nidan Laboratories and Healthcare's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nidan Laboratories and Healthcare's ROA % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Nidan Laboratories and Healthcare's ROA % distribution charts can be found below:

* The bar in red indicates where Nidan Laboratories and Healthcare's ROA % falls into.



Nidan Laboratories and Healthcare ROA % Calculation

Nidan Laboratories and Healthcare's annualized ROA % for the fiscal year that ended in Mar. 2024 is calculated as:

ROA %=Net Income (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=-32.323/( (844.016+825.508)/ 2 )
=-32.323/834.762
=-3.87 %

Nidan Laboratories and Healthcare's annualized ROA % for the quarter that ended in Mar. 2023 is calculated as:

ROA %=Net Income (Q: Mar. 2023 )/( (Total Assets (Q: Sep. 2022 )+Total Assets (Q: Mar. 2023 ))/ count )
=24.428/( (872.904+844.016)/ 2 )
=24.428/858.46
=2.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Mar. 2023) net income data. ROA % is displayed in the 30-year financial page.


Nidan Laboratories and Healthcare  (NSE:NIDAN) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Mar. 2023 )
=Net Income/Total Assets
=24.428/858.46
=(Net Income / Revenue)*(Revenue / Total Assets)
=(24.428 / 203.546)*(203.546 / 858.46)
=Net Margin %*Asset Turnover
=12 %*0.2371
=2.85 %

Note: The Net Income data used here is two times the semi-annual (Mar. 2023) net income data. The Revenue data used here is two times the semi-annual (Mar. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Nidan Laboratories and Healthcare ROA % Related Terms

Thank you for viewing the detailed overview of Nidan Laboratories and Healthcare's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nidan Laboratories and Healthcare Business Description

Traded in Other Exchanges
N/A
Address
Vartak Road, SY No. 294/A H. No. 18, Swapnshilpa, Behind Aarti Apartment, Virar West, Palagar, MH, IND, 401303
Nidan Laboratories and Healthcare Ltd offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to radiology tests including computerized tomography scans, magnetic resonance imaging scans.

Nidan Laboratories and Healthcare Headlines

No Headlines